Over half a century, treatment of thyroid autonomy with an oral dose of iodine-131 has
proven to be effective. The optimum management strategy for the patient is, however, still a …

The present study analyzes the improvement of the outcome of radioiodine therapy in non-
immunogenic hyperthyroidism by adapting the target dose to the 99mTc-pertechnetate …

The aim of this study was to optimise radioiodine therapy of diffuse and nodular toxic goitre
by calculation of the radiation dose delivered to the thyroid on the basis of the pretreatment …

Radioiodine therapy is now the most common definite treatment for persistent
hyperthyroidism. The outcome of radioiodine therapy depends mainly on the absorbed …

BACKGROUND: When planning radioactive iodine therapy, itfrequently happens, both in
Poland and world-wide, that inadequateattention is paid to such easily measurable …

Objective The long-term effects of (131) I-therapy in patients with symptomatic non-toxic
diffuse goitre were evaluated. Design and Methods In a prospective open study, 34 patients …

Methods We retrospectively reviewed the records of 88 patients who received 131I
(intended dose of 80 Gy) for an ATN, of whom 39 had evidence of extranodular activity …

Radioiodine (131I) therapy of benign thyroid diseases was introduced 70 yr ago, and the
patients treated since then are probably numbered in the millions. Fifty to 90% of …

Aim The use of radioiodine therapy is common in the treatment of benign thyroid disease.
Council directive Euratom 97/43 requires that for all medical exposure of individuals for …

In this review, the causes of thyrotoxicosis and the treatment of syndromes with increased
trapping of iodine are discussed. The benefits and the potential side effects of 3 frequently …